我们能相信左西孟旦吗？ - Suppr

Suppr

超能文献

Can we believe in levosimendan?

作者信息

Follath Ferenc

出版信息

Arq Bras Cardiol. 2008 Mar;90(3):146-7. doi: 10.1590/s0066-782x2008000300001.

DOI:10.1590/s0066-782x2008000300001

PMID:18392391

Abstract

摘要

相似文献

Can we believe in levosimendan?

Arq Bras Cardiol. 2008 Mar;90(3):146-7. doi: 10.1590/s0066-782x2008000300001.

Patients with advanced heart failure and the effects of levosimendan.

Am J Cardiol. 2007 Aug 15;100(4):742; author reply 742-3. doi: 10.1016/j.amjcard.2007.01.008. Epub 2007 Mar 26.

Levosimendan use in several scenarios of acute heart failure.

Arq Bras Cardiol. 2008 Mar;90(3):211-5. doi: 10.1590/s0066-782x2008000300012.

Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.

Int J Cardiol. 2008 Aug 1;128(1):91-3; author reply 94-6. doi: 10.1016/j.ijcard.2008.01.034. Epub 2008 May 21.

Levosimendan in patients with decompensated heart failure.

Arq Bras Cardiol. 2008 Aug;91(2):119. doi: 10.1590/s0066-782x2008001400010.

Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients.

Am J Cardiol. 2007 Jan 1;99(1):146-7. doi: 10.1016/j.amjcard.2006.10.007. Epub 2006 Nov 29.

A struggle to SURVIVE: to abandon or not to abandon levosimendan?

Cardiovasc Drugs Ther. 2007 Oct;21(5):401-2. doi: 10.1007/s10557-007-6046-y.

Effect of outpatient administration of levosimendan in reducing hospital readmission in patients with heart failure.

Med Clin (Barc). 2023 Nov 10;161(9):403-404. doi: 10.1016/j.medcli.2023.06.049. Epub 2023 Aug 17.

Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.

Eur J Heart Fail. 2007 Jan;9(1):75-82. doi: 10.1016/j.ejheart.2006.04.012. Epub 2006 Jul 7.

[Levosimendan in heart failure].

Recenti Prog Med. 2004 Jul-Aug;95(7-8):376-83.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Can we believe in levosimendan?

Arq Bras Cardiol. 2008 Mar;90(3):146-7. doi: 10.1590/s0066-782x2008000300001.

Patients with advanced heart failure and the effects of levosimendan.

Am J Cardiol. 2007 Aug 15;100(4):742; author reply 742-3. doi: 10.1016/j.amjcard.2007.01.008. Epub 2007 Mar 26.

Levosimendan use in several scenarios of acute heart failure.

Arq Bras Cardiol. 2008 Mar;90(3):211-5. doi: 10.1590/s0066-782x2008000300012.

Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.

Int J Cardiol. 2008 Aug 1;128(1):91-3; author reply 94-6. doi: 10.1016/j.ijcard.2008.01.034. Epub 2008 May 21.

Levosimendan in patients with decompensated heart failure.

Arq Bras Cardiol. 2008 Aug;91(2):119. doi: 10.1590/s0066-782x2008001400010.

Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients.

Am J Cardiol. 2007 Jan 1;99(1):146-7. doi: 10.1016/j.amjcard.2006.10.007. Epub 2006 Nov 29.

A struggle to SURVIVE: to abandon or not to abandon levosimendan?

Cardiovasc Drugs Ther. 2007 Oct;21(5):401-2. doi: 10.1007/s10557-007-6046-y.

Effect of outpatient administration of levosimendan in reducing hospital readmission in patients with heart failure.

Med Clin (Barc). 2023 Nov 10;161(9):403-404. doi: 10.1016/j.medcli.2023.06.049. Epub 2023 Aug 17.

Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.

Eur J Heart Fail. 2007 Jan;9(1):75-82. doi: 10.1016/j.ejheart.2006.04.012. Epub 2006 Jul 7.

[Levosimendan in heart failure].

Recenti Prog Med. 2004 Jul-Aug;95(7-8):376-83.